Clinical Trials
3
Active:1
Completed:2
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Celltrion Pharm, Inc.
- Target Recruit Count
- 3438
- Registration Number
- NCT04470817
- Locations
- 🇰🇷
Myongji Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea
Completed
- Conditions
- Essential Hypertension
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Celltrion Pharm, Inc.
- Target Recruit Count
- 718
- Registration Number
- NCT04470830
- Locations
- 🇰🇷
Yeungnam University Medical Center, Daegu, Gyeongsangbuk-do, Korea, Republic of
A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy
Phase 4
Active, not recruiting
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2018-04-17
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Celltrion Pharm, Inc.
- Target Recruit Count
- 133
- Registration Number
- NCT03499704
- Locations
- 🇰🇷
The Catholic University of Korea, Bucheon, St. Marys Hospital, Bucheon-si, Gyeonggi-do, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷The Catholic University of Korea, ST. Vincents Hospital, Suwon-si, Gyeonggi-do, Korea, Republic of
News
No news found